Hyundai Pharm (004310) — Free Cash Flow Generation Index

Latest as of February 2026: -12.77x

Hyundai Pharm (004310) has a Free Cash Flow Generation Index of -12.77x as of February 2026. Free cash flow of ₩-2.40 Billion represents -13% of operating cash flow (₩188.28 Million). Read debt load of Hyundai Pharm for a breakdown of total debt and financial obligations.

FCF Generation Index

-12.77x
Free Cash Flow / Operating CF

Free Cash Flow

₩-2.40 Billion
KRW

Operating Cash Flow

₩188.28 Million
KRW

Capital Expenditures

₩2.59 Billion
KRW

Hyundai Pharm Free Cash Flow Generation Index (2010–2022)

Historical FCF Generation Index trend for Hyundai Pharm across 8 annual periods. Explore Hyundai Pharm capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Hyundai Pharm (2010–2022)

Year-by-year Free Cash Flow Generation Index for Hyundai Pharm. For the full company profile including market capitalisation, see 004310 market cap overview.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2022 0.43x ₩5.04 Billion ₩11.62 Billion ₩6.58 Billion ▲ +232.7%
2021 -0.33x ₩-1.68 Billion ₩5.13 Billion ₩6.81 Billion ▼ -180.2%
2020 0.41x ₩4.40 Billion ₩10.80 Billion ₩6.40 Billion ▼ -15.4%
2019 0.48x ₩3.35 Billion ₩6.96 Billion ₩2.36 Billion ▲ +712.5%
2018 0.06x ₩168.09 Million ₩2.83 Billion ₩2.67 Billion ▼ -95.4%
2013 1.28x ₩10.19 Billion ₩7.95 Billion ₩2.24 Billion ▼ -19.3%
2011 1.59x ₩9.95 Billion ₩6.27 Billion ₩3.68 Billion ▼ -35.8%
2010 2.47x ₩6.62 Billion ₩2.68 Billion ₩3.95 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).